We are NeoNest Global
In developing regions, neonatal hypothermia remains a critical yet preventable threat to newborn health. NeoNest Global is committed to addressing this challenge. Our mission is to create innovative, sustainable solutions that make life-saving care accessible for vulnerable newborns worldwide.
In low-resource settings where access to incubators is limited, neonatal hypothermia claims over 1 million lives each year.
We aim to provide accessible, non electricity dependent incubators to underserved hospitals and clinics, bringing life-saving support to the newborns who need it most.
The Global Burden of Neonatal Death
The Stats.
Neonates are most vulnerable to temperature drops in their first 28 days.
When their temperature drops below 36.5°C, they enter hypothermia—a critical condition that disrupts vital functions and can rapidly become life-threatening if not treated.
80% of high-risk infants are hypothermic upon hospital admission.
Without proper intervention, neonatal hypothermia can be a major comorbidity for neonatal infection and asphyxia, contributing to neonatal death.
A 1°C drop in a newborn's temperature increases risk of death by 80%.
Even a small drop in temperature can compromise vital organ functions, highlighting the importance of accessible and effective warming solutions.
NeoNest in Action
-
VentureWell E-Team Cohort
In Spring 2024, NeoNest joined the VentureWell E-Team Program, a prestigious initiative focused on refining business models in the medtech sector.
-
Michigan Business Challenge
NeoNest was the runner-up in the annual Michigan Business Challenge. Competing against over 120 teams, NeoNest placed in the Seigle Impact Track.
-
Johns Hopkins Healthcare Competition
Chosen from 286 proposals and 123 universities, NeoNest ranked among the Top 8 internationally in the JHU Design Competition.
-
P&Q Most Disruptive Business School Startups
NeoNest joined the 2024 cohort of the Most Disruptive startups list, honoring startups from the nation’s top business schools.